Actimed Therapeutics Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)
Phase 1
Completed
- Conditions
- Cachexia
- Interventions
- Drug: Part 1 Group 2 Regimen C (Pindolol)Drug: Part 1 Group 1 Regime A (ACM-001.1)Drug: Part 2 Group G (ACM-001.1)Drug: Part 2 Group D (Pindolol)Drug: Part 2 Group E (ACM-001.1)Drug: Part 2 Group F (ACM-001.1 )Drug: Part 1 Group 1 Regimen B (Pindolol)Other: Part 2 Group G ( Placebo)Other: Part 2 Group E (Placebo)Other: Part 2 Group F (Placebo)Other: Part 1 Group 1 Regimen A (Placebo)
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Actimed Therapeutics Ltd
- Target Recruit Count
- 51
- Registration Number
- NCT06028321
- Locations
- 🇬🇧
Quotient Sciences Ltd, Ruddington, United Kingdom
News
No news found